Medias Klinikum GmbH & Co KG Press Releases - EIN Presswire

Published on April 8, 2020 - 09:41 GMT

Regional chemotherapy for head and neck cancers prolongs survival and maintains quality of life

Intra-arterial infusion- and isolated perfusion chemotherapy for advanced stage IVA, IVB/C head and neck cancers prolongs survival and maintains quality of life BURGHAUSEN, GERMANY, April 8, 2020 /⁨EINPresswire.com⁩/ -- The various therapies for the …

Distribution channels: Companies, Culture, Society & Lifestyle ...

Published on April 8, 2020 - 09:41 GMT

Advanced ovarian cancer: Regional chemotherapy leads to rapid remissions and maintains quality of life

Recent study on advanced ovarian cancer: Isolated perfusion therapy with chemofiltration leads to rapid remissions with maintained and improved quality of life BURGHAUSEN, GERMANY, April 8, 2020 /⁨EINPresswire.com⁩/ -- Ovarian tumours are among the most …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on April 16, 2019 - 12:49 GMT

Positive results of regional perfusion chemotherapy for progressive and refractory ovarian cancer made public today

Hypoxic abdominal perfusion for progressive and refractory ovarian cancer is an effective therapy offering comparably long survival at good quality of life BURGHAUSEN, GERMANY, April 16, 2019 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, a …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on March 14, 2019 - 13:46 GMT

Regionale Chemotherapie (RCT) bei Brustkrebs: Ergebnisse einer retrospektiven Beobachtungsstudie

Ergebnisse einer multizentrisch retrospektiven Beobachtungsstudie mit 162 Patienten mit fortgeschrittenem metastasierten Mammakarzinom. BURGHAUSEN, GERMANY, March 14, 2019 /⁨EINPresswire.com⁩/ -- Mit jährlich 70.000 Neuerkrankungen in Deutschland führt …

Distribution channels: Beauty & Hair Care, Companies ...

Published on January 30, 2019 - 16:11 GMT

Medias Klinikum’s Recently Results Reinforce and Extend the Positive Effects of Regional Chemotherapy for HN Cancer

Results from an ongoing phase-II-study of intra-arterial infusion chemotherapy for HN cancer published in the Journal of Cancer Research and Clinical Oncology BURGHAUSEN, GERMANY, January 30, 2019 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on October 23, 2018 - 11:40 GMT

Results from an ongoing phase II study of isolated abdominal perfusion for chemoresistant and recurrent ovarian cancer

Favorable study results of regional chemotherapy for recurrent ovarian cancer presented at the 38th Congress of the European Society of Surgical Oncology BURGHAUSEN, GERMANY, October 23, 2018 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, a …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on October 23, 2018 - 11:39 GMT

Improved tumor control and quality of life: Results of a new treatment approach for head and neck cancers

Medias Klinikum highlights improvement to standard therapies for head and neck cancers during the 38th Congress of the European Society of Surgical Oncology BURGHAUSEN, GERMANY, October 23, 2018 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, a …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on September 5, 2018 - 15:47 GMT

New Treatment Approach to Avoid Treatment Related Suicide Among Head and Neck Cancer Survivors

Results of a new treatment approach for head and neck cancers published in the World Journal of Surgical Oncology BURGHAUSEN, GERMANY, September 5, 2018 /⁨EINPresswire.com⁩/ -- Among cancer survivors, head and neck cancer patients have the highest risk …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on April 17, 2018 - 11:43 GMT

New Treatment Approach for Head and Neck Cancers via Implantable Arterial Port Catheters

Medias Klinikum Highlights Positive Improvement to Standard Therapies for Head and Neck Cancers to be Presented at the 5th World Congress on Vascular Access BURGHAUSEN, GERMANY, April 17, 2018 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, a …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on April 11, 2018 - 10:55 GMT

Results from an ongoing phase II study of isolated thoracic perfusion with chemofiltration for pleural mesothelioma

Favorable results from an ongoing study of regional chemotherapy for pleural mesothelioma presented at the 59th Congress of the German Society for Pneumology BURGHAUSEN, GERMANY, April 11, 2018 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, a …

Distribution channels: Companies, Conferences & Trade Fairs ...

Published on April 11, 2018 - 10:10 GMT

Results from an ongoing phase II study of isolated thoracic perfusion with chemofiltration for pleural mesothelioma

Favorable results from an ongoing study of regional chemotherapy for pleural mesothelioma presented at the 59th Congress of the German Society for Pneumology BURGHAUSEN, GERMANY, April 11, 2018 /⁨EINPresswire.com⁩/ -- Medias Klinikum GmbH & Co KG, a …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...